These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

518 related articles for article (PubMed ID: 21361717)

  • 21. Value-of-information analysis to guide future research in colorectal cancer screening.
    Hassan C; Hunink MG; Laghi A; Pickhardt PJ; Zullo A; Kim DH; Iafrate F; Di Giulio E
    Radiology; 2009 Dec; 253(3):745-52. PubMed ID: 19789242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening for colorectal cancer: the cost to find an advanced adenoma.
    McGrath JS; Ponich TP; Gregor JC
    Am J Gastroenterol; 2002 Nov; 97(11):2902-7. PubMed ID: 12425566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparing risks and benefits of colorectal cancer screening in elderly patients.
    Ko CW; Sonnenberg A
    Gastroenterology; 2005 Oct; 129(4):1163-70. PubMed ID: 16230070
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is virtual colonoscopy a cost-effective option to screen for colorectal cancer?
    Sonnenberg A; Delcò F; Bauerfeind P
    Am J Gastroenterol; 1999 Aug; 94(8):2268-74. PubMed ID: 10445561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness of colorectal cancer screening with computed tomography colonography or fecal blood tests.
    Heresbach D; Chauvin P; Grolier J; Josselin JM
    Eur J Gastroenterol Hepatol; 2010 Nov; 22(11):1372-9. PubMed ID: 20802341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of computer-aided detection on the cost-effectiveness of CT colonography.
    Regge D; Hassan C; Pickhardt PJ; Laghi A; Zullo A; Kim DH; Iafrate F; Morini S
    Radiology; 2009 Feb; 250(2):488-97. PubMed ID: 19188317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon.
    Lieberman DA; Weiss DG;
    N Engl J Med; 2001 Aug; 345(8):555-60. PubMed ID: 11529208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the benefits, harms and cost-effectiveness of potential alternatives to iFOBT testing for colorectal cancer screening in Australia.
    Lew JB; St John DJB; Macrae FA; Emery JD; Ee HC; Jenkins MA; He E; Grogan P; Caruana M; Sarfati D; Greuter MJE; Coupé VMH; Canfell K
    Int J Cancer; 2018 Jul; 143(2):269-282. PubMed ID: 29441568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness of colon cancer screening.
    Lieberman D
    Am J Gastroenterol; 1991 Dec; 86(12):1789-94. PubMed ID: 1962624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Which colon cancer screening test? A comparison of costs, effectiveness, and compliance.
    Vijan S; Hwang EW; Hofer TP; Hayward RA
    Am J Med; 2001 Dec; 111(8):593-601. PubMed ID: 11755501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of screening colonoscopy for patients cared for by the Department of Veterans Affairs.
    El-Serag HB; Petersen L; Hampel H; Richardson P; Cooper G
    Arch Intern Med; 2006 Nov; 166(20):2202-8. PubMed ID: 17101937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preferences for colorectal cancer screening techniques and intention to attend: a multi-criteria decision analysis.
    Hummel JM; Steuten LG; Groothuis-Oudshoorn CJ; Mulder N; Ijzerman MJ
    Appl Health Econ Health Policy; 2013 Oct; 11(5):499-507. PubMed ID: 23979875
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Colon Capsule Endoscopy for the Detection of Colorectal Polyps: An Economic Analysis.
    Palimaka S; Blackhouse G; Goeree R
    Ont Health Technol Assess Ser; 2015; 15(15):1-43. PubMed ID: 26366240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening for colorectal cancer.
    Saliangas K
    Tech Coloproctol; 2004 Nov; 8 Suppl 1():s10-3. PubMed ID: 15655587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Test performance of immunologic fecal occult blood testing and sigmoidoscopy compared with primary colonoscopy screening for colorectal advanced adenomas.
    Khalid-de Bakker CA; Jonkers DM; Sanduleanu S; de Bruïne AP; Meijer GA; Janssen JB; van Engeland M; Stockbrügger RW; Masclee AA
    Cancer Prev Res (Phila); 2011 Oct; 4(10):1563-71. PubMed ID: 21750209
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reappraisal of the options for colorectal cancer screening in England.
    Whyte S; Chilcott J; Halloran S
    Colorectal Dis; 2012 Sep; 14(9):e547-61. PubMed ID: 22390210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Population screening for colorectal cancer by flexible sigmoidoscopy or CT colonography: study protocol for a multicenter randomized trial.
    Regge D; Iussich G; Senore C; Correale L; Hassan C; Bert A; Montemezzi S; Segnan N
    Trials; 2014 Mar; 15():97. PubMed ID: 24678896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endoscopist-directed propofol administration versus anesthesiologist assistance for colorectal cancer screening: a cost-effectiveness analysis.
    Hassan C; Rex DK; Cooper GS; Benamouzig R
    Endoscopy; 2012 May; 44(5):456-64. PubMed ID: 22531982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-effectiveness analysis of colorectal cancer screening strategies in Singapore: a dynamic decision analytic approach.
    Wong SS; Leong AP; Leong TY
    Stud Health Technol Inform; 2004; 107(Pt 1):104-10. PubMed ID: 15360784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cutting cost and increasing access to colorectal cancer screening: another approach to following the guidelines.
    Fisher JA; Fikry C; Troxel AB
    Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):108-13. PubMed ID: 16434595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.